Remove 2024 Remove Competition Remove Pharma Remove Prospecting
article thumbnail

Choosing the Right Prospects: A Sales Rep’s Guide

Pharmaceutical Representative Training

Introduction In today’s competitive business environment, sales professionals face the challenge of optimizing their time and resources to achieve success. In this competitive world of sales, especially in pharmaceuticals, the mantra “quality over quantity” holds true. So what is an ICP?

article thumbnail

Overcoming Sales Objections Part 1: Pharma Sales Challenges

Pharmaceutical Representative Training

Introduction Every sales professional has experienced deals collapsing at the last minute due to objections from prospects. In the competitive world of pharmaceutical sales, effectively handling customer objections is crucial for success. There are times when your prospect will have multiple objections at once.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. billion during 2020-2024. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023? from 2022 to 2030, the pharma industry will reach USD 9,241.34

Pharma 52
article thumbnail

Defining Biotech Success in a Challenging Fundraising Environment

PM360

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC.

Biopharma 111
article thumbnail

Pharma is placing bigger bets on fewer, more strategic assets and platforms

Clarivate

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. As companies face the prospect of major revenue challenges over the next few years, securing inorganic growth through strategic alliances is increasingly attractive.

Pharma 59
article thumbnail

HCP Engagement & Education

PM360

There is a fantastic opportunity for medical teams to become a unifying force in pharma, working in unison commercial teams to define customer journeys that ensure physicians receive a much more connected and less disparate experience. HCPs could practice procedures, surgeries, and patient interactions in a safe environment.

article thumbnail

Building Your Brand In Medical Device Sales With Pat Kothe

Evolve Your Success

He reflects on his early career in pharma and B2B sales, and how it led him to his entrepreneurship journey. He had a small stint in pharma at the very beginning of his career and even had a stint in B2B sales right out of college. They don’t know what pharma or diagnostics is. I’m not a pharma guy.

Sales 52